[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI9908182C1 - composições de proteína de matriz para cura de feridas - Google Patents

composições de proteína de matriz para cura de feridas

Info

Publication number
BRPI9908182C1
BRPI9908182C1 BRPI9908182A BRPI9908182A BRPI9908182C1 BR PI9908182 C1 BRPI9908182 C1 BR PI9908182C1 BR PI9908182 A BRPI9908182 A BR PI9908182A BR PI9908182 A BRPI9908182 A BR PI9908182A BR PI9908182 C1 BRPI9908182 C1 BR PI9908182C1
Authority
BR
Brazil
Prior art keywords
wound healing
matrix protein
protein compositions
repair
pharmaceutical
Prior art date
Application number
BRPI9908182A
Other languages
English (en)
Inventor
Andersson Christer
Slaby Ivan
Hammarström Lars
Lyngstadaas Petter
Gestrelius Stina
Hammargren Tomas
Original Assignee
Biora Ab
Biora Bioex Ab
Straumann Inst Ag
Straumann Holding Ag
Straumann Villeret S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biora Ab, Biora Bioex Ab, Straumann Inst Ag, Straumann Holding Ag, Straumann Villeret S A filed Critical Biora Ab
Priority claimed from PCT/IB1999/000337 external-priority patent/WO1999043344A2/en
Publication of BRPI9908182B1 publication Critical patent/BRPI9908182B1/pt
Publication of BRPI9908182B8 publication Critical patent/BRPI9908182B8/pt
Publication of BRPI9908182C1 publication Critical patent/BRPI9908182C1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)

Abstract

"composições de proteína de matriz para cura de feridas". substâncias ativas de esmalte podem ser usadas para preparação de uma composição farmacêutica ou cosmética para cura de uma ferida, aperfeiçoamento de cura de uma ferida, regeneração ou reparo de tecido liso ou para prevenir ou tratar infecção de inflamação.
BRPI9908182A 1998-02-27 1999-02-26 composições de proteína de matriz para cura de feridas BRPI9908182C1 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DK27098 1998-02-27
DKPA199800270 1998-02-27
US8155198P 1998-04-13 1998-04-13
US60/081.551 1998-04-13
DKPA199801328 1998-10-16
DKPA199801328 1998-10-16
PCT/IB1999/000337 WO1999043344A2 (en) 1998-02-27 1999-02-26 Matrix protein compositions for wound healing

Publications (3)

Publication Number Publication Date
BRPI9908182B1 BRPI9908182B1 (pt) 2017-09-26
BRPI9908182B8 BRPI9908182B8 (pt) 2018-08-14
BRPI9908182C1 true BRPI9908182C1 (pt) 2021-05-25

Family

ID=34395112

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9908182A BRPI9908182C1 (pt) 1998-02-27 1999-02-26 composições de proteína de matriz para cura de feridas

Country Status (6)

Country Link
US (3) US6503539B2 (pt)
JP (1) JP4726296B2 (pt)
AR (1) AR020055A1 (pt)
BR (1) BRPI9908182C1 (pt)
PL (1) PL204797B1 (pt)
RU (1) RU2241489C2 (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1059934T3 (da) * 1998-02-27 2002-11-11 Biora Bioex Ab Matrixproteinpræparater til sårheling
US6884427B1 (en) * 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
US6979670B1 (en) * 1999-03-10 2005-12-27 Biora Bioex Ab Matrix protein compositions for grafting
US20030096740A1 (en) * 1999-03-10 2003-05-22 Lars Hammarstrom Matrix protein compositions for induction of apoptosis
EP1226138B1 (en) * 1999-10-08 2004-12-29 Affinium Pharmaceuticals, Inc. Fab i inhibitors
US6821953B1 (en) * 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
US7304030B2 (en) * 2000-06-20 2007-12-04 Biora Ab Matrix protein composition for dentin regeneration
AU2001274374A1 (en) * 2000-06-20 2002-01-02 Biora Ab Matrix protein compositions for dentin regeneration
AU7920901A (en) * 2000-08-08 2002-03-04 Bioamide Inc Scaffolds for tissue engineered hair
US7144729B2 (en) 2000-09-01 2006-12-05 Dfb Pharmaceuticals, Inc. Methods and compositions for tissue regeneration
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
ATE368380T1 (de) * 2001-01-12 2007-08-15 Univ Texas Neue antiseptische derivate mit breitem antimikrobiellem wirkungsspektrum zur imprägnierung von oberflächen
US7033611B2 (en) * 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
US7049310B2 (en) * 2001-04-06 2006-05-23 Affinium Pharmaceuticals, Inc. Fab I inhibitors
CN100346823C (zh) * 2001-09-14 2007-11-07 比奥拉比奥埃克斯公司 用于调节免疫反应的釉质基质蛋白组合物
JP2005516032A (ja) 2002-01-23 2005-06-02 デンツプライ インターナショナル インコーポレーテッド 洗浄液とその使用法
US20040068284A1 (en) * 2002-01-29 2004-04-08 Barrows Thomas H. Method for stimulating hair growth and kit for carrying out said method
JP4948744B2 (ja) * 2002-10-04 2012-06-06 允 深江 歯周組織再生剤、その有効成分抽出法、およびプラスミド
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
US8778889B2 (en) * 2003-03-10 2014-07-15 The United States Of America As Represented By The Secretary Of The Army Antimicrobial decapeptide oral hygiene treatment
US7494980B2 (en) * 2003-03-10 2009-02-24 The United States Of America As Represented By The Secretary Of The Army Antimicrobial peptide and methods of use thereof
CA2519429C (en) * 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US7601731B2 (en) * 2003-06-06 2009-10-13 Board Of Regents, The University Of Texas System Antimicrobial flush solutions
PL1641783T3 (pl) * 2003-06-19 2012-08-31 Janssen Pharmaceutica Nv 4-(aminometylo)-piperydyno-benzamidy podstawione aminosulfonylem jako antagoniści 5HT₄
EP1680148A1 (en) * 2003-10-21 2006-07-19 Bioartificial Gel Technologies Inc. Hydrogel-containing medical articles and methods of using and making the same
US20050125015A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Tissue-handling apparatus, system and method
US20050125033A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Wound closure apparatus
WO2005072281A2 (en) * 2004-01-20 2005-08-11 Board Of Regents, The University Of Texas System Methods for coating and impregnating medical devices with antiseptic compositions
US7597885B2 (en) * 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
AR050212A1 (es) * 2004-08-13 2006-10-04 Aderans Res Inst Inc Organogenesis a partir de celulas disociadas
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
JP5069125B2 (ja) * 2004-12-10 2012-11-07 シュトラウマン・ホールディング・アクチェンゲゼルシャフト 新規なタンパク質配合物
SE0403014D0 (sv) * 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
JP2008534674A (ja) * 2005-04-09 2008-08-28 允 深江 シースプロテインを含有するタンパク質、及びそれを導くポリペプチド断片あるいはペプチド断片、並びにシースプロテインを含有する会合体を含む成分
US20070048356A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial treatment of nonwoven materials for infection control
US20070048344A1 (en) * 2005-08-31 2007-03-01 Ali Yahiaoui Antimicrobial composition
US20070048358A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial substrates
US20070048345A1 (en) * 2005-08-31 2007-03-01 Kimberly-Clark Worldwide, Inc. Antimicrobial composition
EP1960013B1 (en) 2005-11-18 2016-12-21 The Board of Regents of The University of Texas System Methods for coating surfaces with antimicrobial agents
TW200800240A (en) * 2005-11-22 2008-01-01 Aderans Res Inst Inc Hair follicle graft from tissue engineered skin
US20070122387A1 (en) * 2005-11-22 2007-05-31 Aderans Research Institute, Inc. Hair grafts derived from plucked hair
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
US20070135706A1 (en) * 2005-12-13 2007-06-14 Shimko Daniel A Debridement method, device and kit
US20070148187A1 (en) * 2005-12-27 2007-06-28 Intact Enterprises, Inc. Mastic gum composition for use as a dietary supplement in humans and animals
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
US7772213B2 (en) * 2006-07-27 2010-08-10 Nathan Strick Composition for the treatment of inflammatory conditions
US8623842B2 (en) * 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
US20090202615A1 (en) 2007-02-19 2009-08-13 Plurogen Therapeutics, Inc. Compositions for Treating Biofilms and Methods for Using Same
US7985537B2 (en) * 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
CA2763368A1 (en) * 2009-05-13 2010-11-18 Protein Delivery Solutions, Llc Pharmaceutical system for trans-membrane delivery
EP3205344A1 (en) * 2009-05-19 2017-08-16 Plurogen Therapeutics, LLC Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing
US9192626B2 (en) * 2009-06-10 2015-11-24 American Silver, Llc Dental uses of silver hydrosol
CN101991688A (zh) * 2009-08-20 2011-03-30 徐荣祥 药物组合物在制备治疗糖尿病溃疡药物中的用途
US8790613B2 (en) * 2010-02-24 2014-07-29 Erachem Comilog, Inc. Treated electrolytic manganese dioxide and method for its production
US9789190B2 (en) * 2010-10-15 2017-10-17 Straumann Holding Ag EMD formulation comprising PGA
BR112013030381B1 (pt) 2011-05-27 2021-10-26 University Of Washington Through Its Center For Commercialization Produto de cuidado oral
EP2861608B8 (en) 2012-06-19 2019-06-19 Debiopharm International SA Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US20140023979A1 (en) * 2012-07-18 2014-01-23 Maha Mohamed Fouad Mounir Regeneration of ameloblast cells and dental enamel in vivo
US9155671B2 (en) 2012-10-16 2015-10-13 Surmodics, Inc. Wound packing device and methods
US20140186273A1 (en) * 2012-12-27 2014-07-03 University Of Southern California Chitosan -Amelogenin Hydrogel for In Situ Enamel Growth
US20140272803A1 (en) * 2013-03-14 2014-09-18 Alan Nevins Root canal for tissue in-growth
WO2014177602A1 (en) * 2013-04-30 2014-11-06 Straumann Holding Ag Trap 63
EP3094308B1 (en) * 2014-01-17 2018-12-26 Straumann Holding AG Process for producing emd of increased stability
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
CA2974361A1 (en) 2015-01-20 2016-07-28 Plurogen Therapeutics, Llc Compositions and methods of treating microbes
US9962465B2 (en) 2015-07-07 2018-05-08 University Of Southern California Amelogenin-chitosan hydrogel for dentin hypersensitivity
US10952940B2 (en) 2016-01-15 2021-03-23 University Of Washington Reagents and methods for mineralization of tooth enamel
JP6952353B2 (ja) 2016-01-31 2021-10-20 メディウーンド リミテッド 創傷を治療するためのデブリードマン組成物
MY189221A (en) 2016-02-26 2022-01-31 Debiopharm Int Sa Medicament for treatment of diabetic foot infections
WO2017183018A1 (en) * 2016-04-18 2017-10-26 Mediwound Ltd Methods of debridement of chronic wounds
US11457996B2 (en) * 2019-09-12 2022-10-04 King Abdulaziz University Dental pulp capping composition and method of preserving and regenerating capped pulp and dentin bridge
EP4262748A1 (en) * 2020-12-21 2023-10-25 Biointelligent Technology Systems SLU A mucosal re-epithelialization composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454480B (sv) 1986-09-25 1988-05-09 Lars Hammarstrom Bindningsinducerande komposition
SE461313B (sv) * 1988-03-17 1990-02-05 Biora Ab Bindningsinducerande komposition
SE503096C2 (sv) 1994-09-22 1996-03-25 Biora Ab Komposition innehållande EDTA för användning vid konditionering av tandrötter
DE69635081T2 (de) 1995-07-13 2006-06-01 Biora Ab Schmelz-Matrix betreffende Polypeptide

Also Published As

Publication number Publication date
US20020169105A1 (en) 2002-11-14
BRPI9908182B8 (pt) 2018-08-14
US20050271604A1 (en) 2005-12-08
US20030064927A1 (en) 2003-04-03
US7294352B2 (en) 2007-11-13
RU2241489C2 (ru) 2004-12-10
JP4726296B2 (ja) 2011-07-20
PL204797B1 (pl) 2010-02-26
BRPI9908182B1 (pt) 2017-09-26
US6503539B2 (en) 2003-01-07
AR020055A1 (es) 2002-04-10
US6720009B2 (en) 2004-04-13
JP2002504520A (ja) 2002-02-12

Similar Documents

Publication Publication Date Title
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
BR9908182A (pt) Composições de proteìna de matriz para cura deferidas
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
BRPI0112962B8 (pt) composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
BR9809117A (pt) Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
BR9702200A (pt) Compostos bicíclicos-aromáticos composição farmacéutica composição cosmética e utilização de uma composição cosmética
BR9702144A (pt) Compostos propinil biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
BR0214644A (pt) Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação
BR9814436A (pt) Composição de microsferas para curar feridas